Have a personal or library account? Click to login
Antidiabetic agents as potential cytotoxic candidates for cancer therapy Cover

Antidiabetic agents as potential cytotoxic candidates for cancer therapy

Open Access
|Jun 2025

Figures & Tables

Figure 1:

Difference in glucose metabolism between normal and cancer cells [22].
Difference in glucose metabolism between normal and cancer cells [22].

Figure 2:

Internal metabolism of cancer cells.
Internal metabolism of cancer cells.

Summary of the cytotoxic effects of some antidiabetic drugs_

Antidiabetics classDrug nameTumor typesReferences
BiguanideMetforminBreast cancer[45]

Colorectal cancer[46]

Endometrial cancer[47]

Ovarian cancer[183]

Skin cancer[184,185]

Thyroid cancer[186]

Head and neck cancer[175]

Pancreatic cancer[187]

Lung cancer[54]

SulfonylureaGlibenclamideGastric cancer[76]

Breast cancer[69]

Hepatocellular carcinoma[70,73]

Colon cancer[75]

Glioblastoma[72]

ThiazolidinedioneRosiglitazoneNeuroblastoma[83]

GliptinsVildagliptin and sitagliptinColorectal cancer[96,102] [97]

Vildagliptin, sitagliptin, and gemigliptinThyroid cancer[93,104,105]

Vildagliptin, sitagliptin, and sitagliptinChronic myeloid leukemia[106,107]

VildagliptinLung cancer[103]

SitagliptinGastric cancer[94]

Breast cancer[98]

Endometrial cancer[95]

Cervical carcinoma[99]

Glioblastoma cancer in the brain[100,101]

GLP-1 agonistsExenatide-4Hepatocellular carcinoma[112,113]

Breast cancer[114]

Prostate cancer[115]

Endometrial cancer[116]

LiraglutideEndometrial cancer[116]

SGLT2 inhibitorsDapagliflozinPancreatic carcinoma[38,123]
Renal carcinoma (in humans)[129]
Human colon carcinoma[188]

CanagliflozinPancreatic cancer and early-stage lung cancer[38,125,189] [130]
Hepatocellular carcinoma (in humans)[190]
Lung cancer[191]
Breast cancer[191,192]
Prostate cancer[192]
Thyroid cancer[131]

IpragliflozinBreast carcinoma[128]
DOI: https://doi.org/10.2478/fco-2023-0041 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 68 - 89
Submitted on: Mar 16, 2024
Accepted on: Aug 16, 2024
Published on: Jun 10, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Raniah I. Alnaser, Fawaz A. Alassaf, Mohammed N. Abed, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.